跳至主要内容
临床试验/TCTR20220516003
TCTR20220516003招募中4 期

Test and Treat HIV and Viral Hepatitis for Most at Risk Populations in Central and Southeast Asia: The C-FREE-CSEA Study

Dreamlopments Foundation0 个研究点目标入组 4,800 人开始时间: 2022年5月16日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
4,800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Male, female, or transgender person.
  • Aged 18 years old or older.
  • Former or active injecting or non-injecting drug user. PWID/PWUD are expected to represent the largest sub-population of participants enrolling in the study.
  • Men-who-have-se-with-men (MSM).
  • Sexual or life partner of a current or former drug user, or other high-risk group (MSM, TG women).
  • Consenting to participate in the study.
  • Willing to undertake at least HIV Ab testing and/or HCV Ab testing. Candidates with evidence (written medical/laboratory report) of prior testing (including positive testing) for HIV, HCV, HBV, STI, or LTBI infection can also enroll into the cohort study.
  • Consenting to participant in the study

排除标准

  • Inability, in the opinion of the study staff, to provide an informed consent decision to participate in the study.

研究者

发起方
Dreamlopments Foundation

相似试验

Test and Treat HIV and Viral Hepatitis for Most at... | 临床试验